Ad is loading...
GFACX
Price
$69.11
Change
-$1.16 (-1.65%)
Updated
Nov 15 closing price
MFEJX
Price
$214.61
Change
-$4.77 (-2.17%)
Updated
Nov 15 closing price
Ad is loading...

GFACX vs MFEJX

Header iconGFACX vs MFEJX Comparison
Open Charts GFACX vs MFEJXBanner chart's image
American Funds Growth Fund of Amer C
Price$69.11
Change-$1.16 (-1.65%)
VolumeN/A
CapitalizationN/A
MFS Growth R4
Price$214.61
Change-$4.77 (-2.17%)
VolumeN/A
CapitalizationN/A
GFACX vs MFEJX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. MFEJX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a StrongBuy and MFEJX is a Buy.

FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 298B vs. MFEJX (47B). GFACX (0.00) and MFEJX (0.00) have matching dividends . GFACX was incepted earlier than MFEJX: GFACX (24 years) vs MFEJX (20 years). GFACX is a more actively managed with annual turnover of: 31.00 vs. MFEJX (25.00). MFEJX has a lower initial minimum investment than GFACX: MFEJX (0) vs GFACX (250). MFEJX annual gain was more profitable for investors over the last year : 27.88 vs. GFACX (25.86). MFEJX return over 5 years is better than : 78.57 vs. GFACX (44.67).
GFACXMFEJXGFACX / MFEJX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years20 years-
Gain YTD25.65528.92489%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets298B47B634%
Annual Yield % from dividends0.000.00-
Returns for 1 year25.8627.8893%
Returns for 3 years-8.398.87-95%
Returns for 5 years44.6778.5757%
Returns for 10 years54.23199.3327%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UNFI21.660.21
+0.98%
United Natural Foods
RDY14.17-0.07
-0.49%
Dr. Reddy's Laboratories Ltd
BDSX1.35-0.06
-3.93%
Biodesix
APGE47.25-3.76
-7.36%
Apogee Therapeutics
GXAI1.41-0.35
-19.89%
Gaxosai